ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,487Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 113

$747K Total Retail Price of All Prescriptions

Rank: 6 out of 113

302 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 302 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 302 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

0% of this provider’s 9,612 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 507 474 1 2
FUROSEMIDE 447 403 2 6
METOPROLOL SUCCINATE 384 362 3 10
OMEPRAZOLE 364 360 4 5
LISINOPRIL 315 304 5 3
LEVOTHYROXINE SODIUM 296 268 6 1
CARVEDILOL 217 207 7 25
AMLODIPINE BESYLATE 180 146 8 4
SPIRONOLACTONE 173 135 9 32
CRESTOR 165 150 10 30
AVODART 163 153 11 122
POTASSIUM CHLORIDE 157 148 12 12
CITALOPRAM HBR 157 157 12 17
WARFARIN SODIUM 153 137 14 8
METFORMIN HCL 144 126 15 11
ALLOPURINOL 141 140 16 20
CYMBALTA 138 114 17 37
TRILIPIX 131 118 18 145
TAMSULOSIN HCL 129 119 19 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 126 114 20 34
METFORMIN HCL ER 117 104 21 51
ATORVASTATIN CALCIUM 116 115 22 15
DONEPEZIL HCL 114 114 23 33
ZOLPIDEM TARTRATE 113 94 24 19
SYNTHROID 112 104 25 57
CELEBREX 106 101 26 90
TRAZODONE HCL 101 77 27 41
DIGOXIN 100 99 28 27
LANTUS 99 55 29 38
IPRATROPIUM-ALBUTEROL 94 94 30 104
FENTANYL 92 90 S2 31 43
TRIAMTERENE-HCTZ 91 88 32 26
FLUTICASONE PROPIONATE 90 81 33 39
GLIMEPIRIDE 89 88 34 36
AZITHROMYCIN 88 76 35 65
JANTOVEN 87 87 36 130
ADVAIR DISKUS 83 68 37 35
ZETIA 78 78 38 80
PREDNISONE 78 76 38 28
METOPROLOL TARTRATE 77 68 40 14
GABAPENTIN 76 76 41 18
PANTOPRAZOLE SODIUM 76 65 41 52
OXYCODONE-ACETAMINOPHEN 73 68 S2 43 105
SPIRIVA 72 64 44 54
BUPROPION XL 72 59 44 101
IRBESARTAN 69 61 46 99
NAMENDA 69 69 46 48
VENLAFAXINE HCL ER 67 67 48 55
HYDROCHLOROTHIAZIDE 65 58 49 9
LOSARTAN POTASSIUM 65 54 49 13
TRICOR 61 60 51 150
SPIRONOLACTONE-HCTZ 58 57 52 107
TRIAMCINOLONE ACETONIDE 57 53 53 107
HUMALOG 55 36 54 70
DIOVAN 55 55 54 42
VYTORIN 53 50 56 135
GEMFIBROZIL 53 49 56 61
DETROL LA 53 53 56 128
KLOR-CON M20 51 51 59 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.